Cardiac myxomas are the most common primary tumors of the heart, although they remain rare overall, particularly in elderly male patients. Left atrial myxomas typically present with nonspecific constitutional … Read More
Category: General
Prolonged intra-aortic balloon pump support successfully reversed severe pulmonary hypertension prior to heart transplantation
Heart transplantation remains the gold standard for the treatment of end-stage heart failure, but severe pulmonary hypertension (PH) poses a significant challenge due to the increased risk of complications aft… Read More
Serological Assessment of Alpha Galactosidase, N-Glycolylneuraminic Acid, and Histopathological Observations in Xenograft Recipients
Cureus. 2025 Aug 29;17(8):e91236. doi: 10.7759/cureus.91236. eCollection 2025 Aug.
ABSTRACT
Background and aims The alpha-galactosidase (αGal) epitope and the associated anti-Gal antibodies, along with the non-human sialic acid N-glycolylneuraminic acid (Neu5Gc) and its corresponding anti-Neu5Gc antibodies, represent critical obstacles in the field of xenotransplantation. We present an evaluation of serological and histopathological data from patients who experienced immunological rejection after receiving decellularized xenografts. This study aims to analyze the long-term immune responses that occur following the implantation of these grafts, providing insights into the mechanisms driving rejection and their potential impact on transplant outcomes. Methods Decellularized xenografts, such as bovine pericardium and porcine pulmonary artery treated with a novel patented processing technique, were utilized in cardiovascular surgeries over the course of a decade. Serum samples from patients following xenotransplantation were examined for α-Gal and Neu5Gc titers after various follow-up periods. When explanted during later surgeries, the xenograft materials were assessed histologically using hematoxylin and eosin (H&E), von Kossa, and Movat’s pentachrome staining. Immunohistochemical staining for von Willebrand Factor (vWF), alpha-smooth muscle actin (αSMA), and B lymphocyte antigen CD19 was performed to evaluate endothelialization, calcification, fibrosis, and immune rejection. No healthy volunteers were enrolled as study participants. However, for the purpose of baseline serological comparison, serum samples from one healthy adult blood donor (33/M) were used as the standard. This donor had no history of xenograft implantation or known immune disorders. Results and conclusion Histological evaluation showed human cell infiltration within the decellularized xenograft scaffold, with evidence of reendothelialization on the luminal surface. The neointimal layer had variable thickness, with aligned collagen fibers. Early remodeling was indicated by minimal fibroblastic invasion and the presence of microcapillaries. von Kossa staining revealed insignificant calcium deposits, and immunohistochemistry showed minimal signs of immune rejection. Serological analysis of seven patients revealed varying responses to α-Gal and Neu5Gc. The patients had a mean age of 16.57 years (ranging from three to 52 years) and a mean follow-up period of 6.14 years (ranging from four to nine years) at the time of blood sampling. The study included four patients with bovine pericardium grafts, one with a bovine jugular vein graft, and two with porcine pulmonary artery grafts. Anti-αGal antibody levels were consistent across all patients, while two patients showed no anti-Neu5Gc antibodies. The remaining five patients exhibited titers with a high standard deviation. This in vitro evaluation indicates that decellularized xenografts processed using the patented technology provoke minimal tissue and immune responses, making them safe and durable options for cardiovascular remodeling surgeries.
PMID:40895658 | PMC:PMC12398327 | DOI:10.7759/cureus.91236
A case report of surgical repair of large superior vena cava saccular aneurysm with thrombosis
Superior vena cava aneurysms are very rare mediastinal masses, classified as fusiform or saccular. These lesions are difficult to diagnose, and the optimal treatment strategy remains controversial.
Outcomes of non-operative management of higher grade (II-IV) of blunt traumatic aortic injury
The current clinical practice guidelines for blunt traumatic aortic injury (BTAI) as set by the Society for Vascular Surgery recommend non-operative management in grade I injuries and thoracic endovascular aor… Read More
Correlation of inflammatory burden index with 30-day readmission rates in patients post-elective percutaneous coronary intervention
The 30-day readmission rate post-percutaneous coronary intervention (PCI) is a critical quality metric, yet the factors influencing this outcome are not fully understood. We aimed to investigate the associatio… Read More
Late presentation and diagnosis of concomitant ruptured sinus of valsalva and congenital gerbode defect in an elderly gentleman
Gerbode defect is a left ventricular-to-right atrial shunt. Sinus of Valsalva aneurysm is an abnormal outpouching at the base of the aorta caused by incomplete fusion between aortic media and annulus fibrosus… Read More.
Development of a coordinated interhospital transfer program for cardiac surgery patients
Timely access to specialized cardiac surgical care is essential for optimal outcomes in patients with complex cardiovascular conditions. Interhospital transfer (IHT) programs have the potential to bridge the g… Read More
Paravertebral nerve block versus combined serratus anterior plane and intercostal nerve blocks in thoracoscopic lung segment surgery in elderly: a retrospective study
In order to accelerate the rapid recovery of elderly patients undergoing lung surgery, we tend to use multimodal analgesic protocols. A retrospective analytical study was used to analyse postoperative analgesi… Read More
Surgical management of pulmonary metastases in pseudomyxoma peritonei: a case series highlighting the challenges of non-palpable lesions and surgical margin management
Pseudomyxoma peritonei (PMP) is a rare neoplastic disease that can occasionally present with pulmonary metastases as an even rarer manifestation. Although cytoreductive surgery represents the primary treatment… Read More